About this Research Topic
There is an urgent need to systematically synthesize these parallel fields of research in immunity and neurodegenerative disease. Epidemiological data, mainly driven by COVID-19 research reveal potentially lasting effects of pathogen exposure on cognition, with candidate mechanisms involving immune dysregulation rather than lasting infection. Furthermore, neuropathological and molecular studies corroborate on the overlap between neurodegenerative disease and COVID-19. Current evidence on these mechanisms suggests a convergence on immunity, presenting a unique opportunity to understand how infection can affect cognition, and trigger neurodegeneration. As pathogen exposure appears to be an early step of the process, we may stand to gain a novel class of therapeutics by their study.
In this Research Topic, we aim to explore both epidemiological data and mechanisms that explore the relationship between cognition, neurodegeneration, and infection. Authors should focus on specific aspects, such as:
1. Observational studies on the relationship between cognition and infection exposure, including but not limited to COVID-19.
2. Basic science or translational studies on specific mechanisms that link cognitive impairment, neurodegeneration and immune mechanisms, with a specific interest in type I interferon signaling and innate immunity.
3. Computational biology studies of shared mechanisms between neurodegenerative infectious disease, with a specific interest in dementias.
Types of Manuscripts: 1) Review articles and 2) Original manuscripts
Keywords: cognition, neurodegeneration, inflammation, infection, interferon signalling, immunity, dementia
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.